Xiaoju Max
- Aging top 2%
- Molecular Biology top 5%
- PI3K/AKT/mTOR signaling in cancer 3
- Protein Kinase Regulation and GTPase Signaling 2
- RNA modifications and cancer 1
- Polyamine Metabolism and Applications 1
- Cell Biology top 5%
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 5
- Immunology top 10%
-
- Genetic factors in colorectal cancer 2
-
- Lung Cancer Treatments and Mutations 2
-
- Bacteriophages and microbial interactions 1
- Co-authors
- John BlenisYonghao YuLewis C. CantleyGeorge PoulogiannisGregory R. HoffmanNeil KubicaJudit VillénSteven P. Gygi
- Cited by
- AgingMolecular BiologyCell Biology
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Xiaoju Max
7 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Aging 96
- Molecular Biology 2.3k
- Cell Biology 350
- Cancer Research 275
- Immunology 282
Countries citing papers authored by Xiaoju Max
This map shows the geographic impact of Xiaoju Max's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoju Max with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoju Max more than expected).
Fields of papers citing papers by Xiaoju Max
This network shows the impact of papers produced by Xiaoju Max. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoju Max. The network helps show where Xiaoju Max may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaoju Max, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 1 | |
| 2 | 2020 | 19 | |
| 3 | 2019 | 1 | |
| 4 | 2018 | 0 | |
| 5 | 2018 | 1 | |
| 6 | Phosphoproteomic Analysis Identifies Grb10 as an mTORC1 Substrate That Negatively Regulates Insulin Signalingbreakdown → | 2011 | 672 |
| 7 | Molecular mechanisms of mTOR-mediated translational controlbreakdown → | 2009 | 1994 |
| 8 | 2008 | 245 |
About Xiaoju Max
Xiaoju Max is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology, having authored 8 papers that have together received 2.9k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (5 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Protein Kinase Regulation and GTPase Signaling (2 papers), Genetic factors in colorectal cancer (2 papers), Lung Cancer Treatments and Mutations (2 papers), RNA modifications and cancer (1 paper), Bacteriophages and microbial interactions (1 paper) and Polyamine Metabolism and Applications (1 paper). The work is most often cited by research in Aging (96 citations), Molecular Biology (2.3k citations) and Cell Biology (350 citations). Xiaoju Max has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include John Blenis, Yonghao Yu, Lewis C. Cantley, George Poulogiannis, Gregory R. Hoffman, Neil Kubica, Judit Villén, Steven P. Gygi, Qian Yang and Celeste Richardson. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Cell, Science and Nature Reviews Molecular Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.